News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
261,263 Results
Type
Article (13586)
Company Profile (110)
Press Release (247567)
Section
Business (87948)
Career Advice (462)
Deals (15324)
Drug Delivery (64)
Drug Development (36530)
Employer Resources (49)
FDA (6259)
Job Trends (6185)
News (150028)
Policy (14007)
Tag
Academia (435)
Alliances (23097)
Alzheimer's disease (352)
Approvals (6253)
Artificial intelligence (61)
Bankruptcy (143)
Best Places to Work (4325)
Biotechnology (44)
Breast cancer (42)
Cancer (315)
Career advice (405)
Cell therapy (44)
Clinical research (30402)
Collaboration (155)
Compensation (62)
COVID-19 (747)
C-suite (52)
Data (343)
Diabetes (53)
Diagnostics (1236)
Drug pricing (57)
Earnings (31558)
Employer resources (43)
Events (36738)
Executive appointments (173)
FDA (6439)
Funding (108)
Gene therapy (59)
GLP-1 (292)
Government (1267)
Healthcare (3522)
Infectious disease (765)
Inflammatory bowel disease (46)
Interviews (58)
IPO (5817)
Job creations (2050)
Job search strategy (372)
Layoffs (167)
Legal (3411)
Lung cancer (46)
Manufacturing (99)
Medical device (1261)
Medtech (1263)
Mergers & acquisitions (9542)
Metabolic disorders (168)
Neuroscience (450)
NextGen Class of 2024 (1580)
Non-profit (590)
Northern California (433)
Obesity (101)
Opinion (109)
Patents (53)
People (28460)
Pharmaceutical (64)
Phase I (7904)
Phase II (12857)
Phase III (11552)
Pipeline (183)
Policy (45)
Postmarket research (1399)
Preclinical (3165)
Radiopharmaceuticals (116)
Rare diseases (90)
Real estate (2629)
Regulatory (9821)
Research institute (563)
Resumes & cover letters (55)
Southern California (435)
Startups (1625)
United States (4280)
Vaccines (112)
Weight loss (78)
Date
Today (49)
Last 7 days (264)
Last 30 days (1264)
Last 365 days (12711)
2024 (11621)
2023 (14244)
2022 (19556)
2021 (20068)
2020 (19033)
2019 (14887)
2018 (11713)
2017 (13889)
2016 (13129)
2015 (15472)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (312)
Arizona (42)
Asia (19793)
Australia (2559)
California (1007)
Canada (602)
China (111)
Colorado (42)
Connecticut (42)
Europe (38779)
Florida (152)
Illinois (111)
Indiana (86)
Japan (43)
Kansas (51)
Maryland (155)
Massachusetts (882)
Minnesota (56)
New Jersey (422)
New York (279)
North Carolina (278)
Northern California (433)
Pennsylvania (286)
South America (498)
Southern California (435)
Texas (138)
Virginia (41)
Washington State (71)
261,263 Results for "cannabics pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Radiation Oncology Expert Joins Cannabics Pharmaceuticals’ Board of Advisors
Cannabics Pharmaceuticals Inc. announced today that Dr. Yonina Tova (MD), internationally recognized Radiation Oncologist has joined the company’s Board of Advisors.
October 25, 2021
·
3 min read
Business
Cannabics Pharmaceuticals Appoints a Second Independent Board Member
Cannabics Pharmaceuticals Inc. announced today that it has appointed Dr. Gil Feiler to its Board of Directors as an Independent Director.
July 20, 2021
·
5 min read
Layoffs
Marinus Pharmaceuticals Lays Off 45% of Employees
The November layoffs are the second known workforce reduction this year for Marinus Pharmaceuticals, which previously announced disappointing Phase III results for ganaxolone in two clinical trials.
November 14, 2024
·
1 min read
·
Angela Gabriel
Business
Cannabics Pharmaceuticals Announces Appointment of New Independent Board Member
Cannabics Pharmaceuticals Inc. announced today that it has appointed Dr. Inbar Maymon-Pomeranchik to its Board of Directors as an Independent Director.
July 7, 2021
·
4 min read
BioCapital
Cannabics Pharmaceuticals Files 2 Provisional Patents On Compositions and Methods for Treating Cancer
Cannabics Pharmaceuticals Inc. announced today that it has filed 2 new Provisional Patent applications on Compositions and Methods for treating cancer, including colorectal cancer and early intervention therapy for colorectal cancer patients.
October 18, 2021
·
3 min read
BioCapital
Cannabics Pharmaceuticals Launches a Breast Cancer Treatment Research Program
Cannabics Pharmaceuticals Inc., a global leader in the development of cancer related cannabinoid-based medicine, announced the launching of a new research program for the development of a Breast Cancer antitumor targeting medicine.
June 3, 2021
·
3 min read
BioCapital
Cannabics Pharmaceuticals Launches Psilocybin and Psilocin Research Program
Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today the launching of a new research program using Psylocibin and Psilocin.
April 20, 2021
·
3 min read
BioCapital
Cannabics Pharmaceuticals’ Drug Candidate Exhibits 30% Tumor Volume Reduction in Mice
Cannabics Pharmaceuticals Inc. released today the interim results of its second in-vivo POC study evaluating the efficacy of company’s proprietary drug candidate RCC-33 for the treatment of colorectal cancer on mice.
June 28, 2021
·
4 min read
Business
Cannabics Pharmaceuticals hires Healthcare Investment Banker Dr. David Sans in New York to expand CNBX in Mental Health Diseases
Cannabics Pharmaceuticals Inc . announced today the hire of Dr. David Sans FAARM, PhD, MBA in New York to expand its current pipeline of clinical development assets in Mental Health Diseases.
September 21, 2021
·
4 min read
Business
Neuropsychiatry Expert Dr. Ilya Reznik (MD) Joins Cannabics as Head of Psychedelic Inspired Medicine
Cannabics Pharmaceuticals Inc. announced today that Dr. Ilya Reznik (MD), a renowned Neuropsychiatrist, has joined the company as Head of Psychedelic Inspired Medicine.
September 13, 2021
·
6 min read
1 of 26,127
Next
